Lakewood Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Buy
761
+2
+0.3% +$713 0.17% 94
2025
Q4
$248K Buy
759
+2
+0.3% +$634 0.15% 90
2025
Q3
$214K Buy
757
+1
+0.1% +$290 0.13% 95
2025
Q2
$211K Buy
756
+2
+0.3% +$567 0.14% 92
2025
Q1
$235K Sell
754
-1,723
-70% -$509K 0.16% 89
2024
Q4
$646K Buy
2,477
+2
+0.1% +$593 0.44% 63
2024
Q3
$798K Buy
2,475
+2
+0.1% +$654 0.54% 51
2024
Q2
$773K Buy
2,473
+2
+0.1% +$588 0.54% 54
2024
Q1
$703K Buy
2,471
+2
+0.1% +$585 0.48% 57
2023
Q4
$711K Sell
2,469
-96
-4% -$26.2K 0.55% 49
2023
Q3
$689K Hold
2,565
0.56% 51
2023
Q2
$570K Buy
2,565
+2
+0.1% +$464 0.45% 61
2023
Q1
$620K Buy
2,563
+3
+0.1% +$736 0.51% 56
2022
Q4
$672K Buy
+2,560
New +$686K 0.54% 51

Other funds holding AMGN

Lakewood Asset Management's AMGN Position: Q1 2026 in Review

Lakewood Asset Management increased its Amgen (AMGN) stake by 0.26% in Q1 2026, buying an estimated $713 and bringing the position to 761 shares worth $268K. The position accounts for 0.17% of the portfolio, ranked #94.

Lakewood Asset Management first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $798K in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Lakewood Asset Management held 761 shares of Amgen worth $268K as of Q1 2026.
  • Lakewood Asset Management bought 2 Amgen shares in Q1 2026, an estimated $713.
  • Amgen made up 0.17% of Lakewood Asset Management's portfolio in Q1 2026, its #94 holding.
  • Lakewood Asset Management first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Lakewood Asset Management's Amgen position peaked at $798K in Q3 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Lakewood Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.